Mast cell variations in tumour tissue and with histopathological grading in specimens of prostatic adenocarcinoma

BJU International

Volumn 84, Issue 7, 1999, Pages 851-853

  Sari, A ^a   Serel, T A ^b   Candir O ^c   Ozturk A ^c   Kosar, A ^c  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c NONE

Author keywords

Distribution; Gleason grade; Mast cell; Prostate cancer

Indexed keywords

TOLONIUM CHLORIDE;

ARTICLE; CANCER GRADING; CANCER TISSUE; CELL AGGREGATION; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MAST CELL; MICROSCOPY; PRIORITY JOURNAL; PROSTATE CARCINOMA; STATISTICAL ANALYSIS;

ADENOCARCINOMA; HUMANS; MALE; MAST CELLS; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0032755637     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00245.x     Document Type: Article

References (15)

1. 1 Fisher ER, Fisher B. Role of mast cells in tumor growth. Arch Pathol 1965; 79: 185-91
2. 2 Hartveit F. Mast cells and metachromosia in human breast cancer: Their occurrence, significance and consequences: a preliminary report. J Pathol 1981; 134: 7
3. 3 Farnoush A, McKenzie IC. Proliferation of mast cells in normal and DMBA-treated mouse skin. J Oral Pathol 1984; 13: 359-65
4. 4 Gupta RK. Mast cell variations in prostate and urinary bladder. Arch Pathol 1970; 89: 302-5
5. 5 Gleason DF. The Veterans Administration Co-operative Urological Research Group: histological grading and clinical staging of prostatic carcinoma. In Tannenbaum M ed. Urological Pathology. Philadelphia: Lea and Febinger, 1977: 171-98
6. 6 Tanooka H, Kitamura Y, Sado K, Nagase M, Kondo S. Evidence for involvement of mast cells in tumor suppression in mice. J Natl Cancer Inst 1982; 69: 1305-9
7. 7 Burtin C, Ponvert C, Fray A. Inverse correlation between tumor incidence and tissue histamine levels in W/W, W/+, +/+ mice. J Natl Cancer Inst 1985; 74: 671-4
8. 8 Fisher ER, Sass R, Watkins G, Johal J. Fisher B. Tissue mast cells in breast cancer. Breast Cancer Res Treat 1985; 5: 285-91
9. 9 Graham RM, Graham JB. Mast cells and cancer of the cervix. Surg Gynecol Obstet 1966; 123: 3-9
10. 10 Farram E, Nelson DS. Mouse mast cells as anti-tumor effector cells. Cell Immunol 1980; 55: 294-301
11. 11 Schitteck A, Abon ISSA, Stafford JH, Young D, Zwilling B, James AG. Growth of pulmonary metastates of B16 melanoma in mast cell-free mice. J Surg Res 1985; 38: 24-8
12. 12 Lynch NR, Salomon JC, Turner KJ. Evolutionary development of IgE and the role of anaphylactic-type reactions in resistance to solid tumors. Cancer Immunol Immunother 1978; 4: 223-8
13. 13 Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity: Role of the peroxidasc system. J Exp Med 1981; 153: 520-33
14. 14 Hamaguchi Y, Kanakura Y, Fujita J. Interleukin 4 as an essential factor in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med 1987; 165: 268-73
15. 15 Dabbous MKh, Walker R, Haney L, Carter LM, Nicolson GL, Wooley DE. Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. Br J Cancer 1986; 54: 459-65